Клинический вестник ФМБЦ им. А.И. Бурназяна. 2023. № 2

 

А.С. Самойлов, Н.В. Рылова, Р. А. Симонов

ПРИМЕНЕНИЕ PRP-ТЕРАПИИ ПРИ ОСТЕОАРТРИТЕ КОЛЕННОГО СУСТАВА
В КЛИНИЧЕСКОЙ И СПОРТИВНОЙ МЕДИЦИНЕ: ОБЗОР ЛИТЕРАТУРЫ

ГНЦ ФМБЦ им. А.И. Бурназяна ФМБА России, Москва

Контактное лицо: Симонов Роман Александрович: roma.simonow2017@yandex.ru

Резюме
Проведен анализ данных отечественной и зарубежной литературы, посвящённый отдельным аспектам применения обогащенной тромбоцитами плазмы при остеоартрите коленного сустава.  По данной тематике обобщен мировой опыт использования PRP в травматологии и спортивной медицине. Поиск проводился с использованием электронных баз данных Pubmed, MEDLINE, Embase, Scopus, eLIBRARY за период с 2003 г. по 2020 г. Для поиска мы использовали ключевые слова и их сочетания: «обогащенная тромбоцитами плазма», «патология хряща», «остеоартрит коленного сустава», «спортсмены». По результатам исследования установлено, что PRP-терапию можно считать полезным методом лечения пациентов с остеоратритом коленного сустава (КОА). По итогам поиска было найдено 248 статей. Девятнадцать исследований соответствовали критериям включения. В доступной литературе опубликовано ограниченное количество достоверных работ. Необходимо проведение дальнейших исследований, чтобы понять краткосрочное и долгосрочное влияние метода PRP на пациентов с КОА.

Ключевые слова: обогащенная тромбоцитами плазма, патология хряща, остеоартрит коленного сустава, спортсмены

Для цитирования: Самойлов А.С., Рылова Н.В., Симонов Р.А. Применение PRP-терапии при остеоартрите коленного сустава в клинической и спортивной медицине: обзор литературы // Клинический вестник ФМБЦ им. А.И. Бурназяна 2023. №2. С. 05–12. DOI: 10.33266/2782-6430-2023-2-5-12

 

СПИСОК ИСТОЧНИКОВ

1. Chahla J., Stone J., Mandelbaum B.R. How to Manage Cartilage Injuries? // Arthroscopy. 2019. Vol. 35, N 10. P. 2771–2773.

2. Ding C., Cicuttini F., Scott F. [et al.]. Natural history of knee cartilage defects and factors affecting change // Arch. Int. Med. 2006. Vol.166, N 6. P. 651–658.

3. Hoburg A., Löer I., Körsmeier K. [et al.]. Matrix-Associated Autologous Chondrocyte Implantation Is an Effective Treatment at Midterm Follow-up in Adolescents and Young Adults // The Orthopaedic J. of Sports Medicine. 2019. Vol. 7, N 4. DOI 10.1177/2325967119841077.

4. Mor A., Grijota M., Norgaard M. [et al.]. Trends in arthroscopy- documented cartilage injuries of the knee and repair procedures among 15–60-year-old patients // Scand. J. Med. Sci. Sports. 2015. Vol. 25, N 4. P. e400–407. DOI 10.1111/sms.12330.

5. Zamborsky R., Danisovic L. Surgical Techniques for Knee Cartilage Repair: An Updated Large-Scale Systematic Review and Network Meta-analysis of Randomized Controlled Trials // Arthroscopy. 2020. Vol. 36, N 3. P. 845–858. DOI 10.1016/j.arthro.2019.11.096.

6. Michael JW-P, Schlüter-Brust KU, Eysel P (2010) The epidemiology, etiology, diagnosis, and treatment of osteoarthritis of the knee. Dtsch Aerzteblatt Online 107:152–162

7. Gouttebarge V, Inklaar H, Backx F, Kerkhoffs G (2015) Prevalence of osteoarthritis in former elite athletes: a systematic overview of the recent literature. Rheumatol Int 35:405–418

8. Wallace IJ, Worthington S, Felson DT, Jurmain RD, Wren KT, Maijanen H, Woods RJ, Lieberman DE. Knee osteoarthritis has doubled in prevalence since the mid-20th century. Proc Natl Acad Sci. 2017;114(35):9332–9336. doi: 10.1073/pnas.1703856114.

9. Mather RC III, Koenig L, Kocher MS, Dall TM, Gallo P, Scott DJ, Bach BR Jr, Spindler KP (2013) Societal and economic impact of anterior cruciate ligament tears. J Bone Joint Surg Am 95:1751–1759

10. Curl WW, Krome J, Gordon ES, Rushing J, Smith BP, Poehling GG. Cartilage injuries: a review of 31,516 knee arthroscopies. Arthroscopy. 1997;13(4 ):456–60.

11. Widuchowski W, Widuchowski J, Trzaska T. Articular cartilage defects: study of 25,124 knee arthroscopies. Knee. 2007;14:177–82.

12. Ortopedija: nacional’noe rukovodstvo/ Pod red. S. P. Mironova, G. P. Kotel’nikova. – 2-e izd., pererabotannoe i dop. – M. : GJeOTAR- Media, 2013.

13. Hafezi-Nejad N., Zikria B., Eng J. [et. al.]. Predictive value of semiquantitative MRI-based scoring systems for future knee replacement: data from the osteoarthritis initiative // Skelet. Radiol. 2015. Vol. 44. P. 1655–1662.

14. Shirazi R., Shirazi-Adl A. Computational biomechanics of articular cartilage of human knee joint: effect of osteochondral defects // J Biomech. 2009. Vol. 42, N 15. P. 2458–2465. DOI 10.1016/j.jbiomech.2009.07.022.

15. Ayhan Egemen. Intraarticular injections (corticosteroid, hyaluronic acid, platelet rich plasma) for the knee osteoarthritis. World Journal of Orthopedics. 2014;5(3):351. doi: 10.5312/wjo.v5.i3.351.

16. Laver L, Marom N, Dnyanesh L, Mei-Dan O, Espregueira-Mendes J, Gobbi A. PRP for degenerative cartilage disease: a systematic review of clinical studies. Cartilage. 2016;8:341–364. doi: 10.1177/1947603516670709.

17. Jang S, Kim J, Cha S. Platelet-rich plasma (PRP) injections as an effective treatment for early osteoarthritis. Eur J Orthop Surg Traumatol. 2012;23:573–580. doi: 10.1007/s00590-012-1037-5.

18. Pearle AD, Warren RF, Rodeo SA. Basic science of articular cartilage and osteoarthritis. Clin Sports Med. 2005;24:1–12. doi: 10.1016/j.csm.2004.08.007.

19. Martel-Pelletier J, Boileau C, Pelletier J, Roughley P. Cartilage in normal and osteoarthritis conditions. Best Pract Res Clin Rheumatol. 2008;22:351–384. doi: 10.1016/j.berh.2008.02.001.

20. Moussa M, Lajeunesse D, Hilal G, El Atat O, Haykal G, Serhal R, et al. Platelet rich plasma (PRP) induces chondroprotection via increasing autophagy, anti-inflammatory markers, and decreasing apoptosis in human osteoarthritic cartilage. Exp Cell Res. 2017;352:146–156.

21. Murray I, Benke M, Mandelbaum B. Management of knee articular cartilage injuries in athletes: chondroprotection, chondrofacilitation, and resurfacing. Knee Surg Sports Traumatol Arthrosc. 2015;24:1617–1626. doi: 10.1007/s00167-015-3509-8.

22. LaPrade R, Dragoo J, Koh J, Murray I, Geeslin A, Chu C. AAOS research symposium updates and consensus. J Am Acad Orthop Surg. 2016;24:e62–e78. doi: 10.5435/JAAOS-D-16-00086.

23. Zlotnicki J, Geeslin A, Murray I, Petrigliano F, LaPrade R, Mann B, et al. Biologic treatments for sports injuries II think tank—current concepts, future research, and barriers to advancement, part 3. Orthop J Sports Med. 2016;4:232596711664243. doi: 10.1177/2325967116642433.

24. Kanchanatawan Wichan, Arirachakaran Alisara, Chaijenkij Kornkit, Prasathaporn Niti, Boonard Manusak, Piyapittayanun Peerapong, Kongtharvonskul Jatupon. Short-term outcomes of platelet-rich plasma injection for treatment of osteoarthritis of the knee. Knee Surgery, Sports Traumatology, Arthroscopy. 2015;24(5):1665–1677. doi: 10.1007/s00167-015-3784-4.

25. Campbell K, Erickson B, Saltzman B, Mascarenhas R, Bach B, Cole B, et al. Is local viscosupplementation injection clinically superior to other therapies in the treatment of osteoarthritis of the knee: a systematic review of overlapping meta-analyses. Arthroscopy. 2015;31:2036–2045.e14. doi: 10.1016/j.arthro.2015.03.030.

26. Patil S, McCauley J, Pulido P, Colwell C. How do knee implants perform past the second decade? Nineteen- to 25-year followup of the press-fit condylar design TKA. Clin Orthop Relat Res. 2014;473:135–140. doi: 10.1007/s11999-014-3792-6.

27. Bannuru RR, Osani MC, Vaysbrot EE, Arden NK, Bennell K, Bierma-Zeinstra S, Kraus VB, Lohmander LS, Abbott JH, Bhandari M, et al. OARSI guidelines for the non-surgical management of knee, hip, and polyarticular osteoarthritis. Osteoarthr Cartil. 2019;27(11):1578–1589. doi: 10.1016/j.joca.2019.06.011.

28. Zhang W, Robertson J, Jones A, Dieppe P, Doherty M. The placebo effect and its determinants in osteoarthritis: meta-analysis of randomised controlled trials. Ann Rheum Dis. 2008;67:1716–1723. doi: 10.1136/ard.2008.092015.

29. Wang P., Yang L., Li H., Lei Z., Yang X., Liu C., Jiang H., Zhang L., Zhou Z., Reinhardt J.D., He C. Effects of whole-body vibration training with quadriceps strengthening exercise on functioning and gait parameters in patients with medial compartment knee osteoarthritis: a randomised controlled preliminary study. Physiotherapy. 2016;102(1):86–92. doi: 10.1016/j.physio.2015.03.3720.

30. Levy D, Petersen K, Scalley Vaught M, Christian D, Cole B. Injections for knee osteoarthritis: corticosteroids, Viscosupplementation, platelet-rich plasma, and autologous stem cells. Arthroscopy. 2018;34:1730–1743. doi: 10.1016/j.arthro.2018.02.022.

31. Machlus K, Thon J, Italiano J. Interpreting the developmental dance of the megakaryocyte: a review of the cellular and molecular processes mediating platelet formation. Br J Haematol. 2014;165:227–236. doi: 10.1111/bjh.12758.

32. Spaková T, Rosocha J, Lacko M, Harvanová D, Gharaibeh A. Treatment of knee joint osteoarthritis with autologous platelet-rich plasma in comparison with hyaluronic acid. Am J Phys Med Rehabil. 2012;91:411–417. doi: 10.1097/PHM.0b013e3182aab72.

33. Sánchez-González D, Méndez-Bolaina E, Trejo-Bahena N. Platelet-rich plasma peptides: key for regeneration. Int J Pept. 2012;2012:1–10. doi: 10.1155/2012/532519.

34. Ludwig Hilary C., Birdwhistell Kate E., Brainard Benjamin M., Franklin Samuel P. Use of a Cyclooxygenase-2 Inhibitor Does Not Inhibit Platelet Activation or Growth Factor Release From Platelet-Rich Plasma. The American Journal of Sports Medicine. 2017;45(14):3351–3357. doi: 10.1177/0363546517730578.

35. Cole B, Seroyer S, Filardo G, Bajaj S, Fortier L. Platelet-rich plasma: where are we now and where are we going? Sports Health. 2010;2:203–210. doi: 10.1177/1941738110366385.

36. Watson S, Bahou W, Fitzgerald D, Ouwehand W, Rao A, Leavitt A. Mapping the platelet proteome: a report of the ISTH Platelet Physiology Subcommittee. J Thromb Haemost. 2005;3:2098–2101. doi: 10.1111/j.1538-7836.2005.01550.x.

37. Xie Xuetao, Zhang Changqing, Tuan Rocky S. Biology of platelet-rich plasma and its clinical application in cartilage repair. Arthritis Research & Therapy. 2014;16(1):204. doi: 10.1186/ar4493.

38. Khoshbin Amir, Leroux Timothy, Wasserstein David, Marks Paul, Theodoropoulos John, Ogilvie-Harris Darrell, Gandhi Rajiv, Takhar Kirat, Lum Grant, Chahal Jaskarndip. The Efficacy of Platelet-Rich Plasma in the Treatment of Symptomatic Knee Osteoarthritis: A Systematic Review With Quantitative Synthesis. Arthroscopy: The Journal of Arthroscopic & Related Surgery. 2013;29(12):2037–2048. doi: 10.1016/j.arthro.2013.09.006.

39. Zhu Y, Yuan M, Meng H, Wang A, Guo Q, Wang Y, et al. Basic science and clinical application of platelet-rich plasma for cartilage defects and osteoarthritis: a review. Osteoarthr Cartil. 2013;21:1627–1637. doi: 10.1016/j.joca.2013.07.017.

40. Nöth Ulrich, Rackwitz Lars, Heymer Andrea, Weber Meike, Baumann Bernd, Steinert Andre, Schütze Norbert, Jakob Franz, Eulert Jochen. Chondrogenic differentiation of human mesenchymal stem cells in collagen type I hydrogels. Journal of Biomedical Materials Research Part A. 2007;83A(3):626–635. doi: 10.1002/jbm.a.31254.

41. Kon E, Filardo G, Di Martino A, Marcacci M. Platelet-rich plasma (PRP) to treat sports injuries: evidence to support its use. Knee Surg Sports Traumatol Arthrosc. 2010;19:516–527. doi: 10.1007/s00167-010-1306-y. 

42. Nasi S, Ea H, So A, Busso N. Revisiting the role of interleukin-1 pathway in osteoarthritis: interleukin-1α and -1β, and NLRP3 inflammasome are not involved in the pathological features of the murine menisectomy model of osteoarthritis. Front Pharmacol 2017;8. 10.3389/fphar.2017.00282.

43. Whitney K, Liebowitz A, Bolia I, Chahla J, Ravuri S, Evans T, et al. Current perspectives on biological approaches for osteoarthritis. Ann N Y Acad Sci. 2017;1410:26–43. doi: 10.1111/nyas.13554.

44. Zhao L, Kaye AD, Abd-Elsayed A. Stem cells for the treatment of knee osteoarthritis: a comprehensive review. Pain Physician. 2018;21:229–241.

45. Braun H, Wasterlain A, Dragoo J. The use of PRP in ligament and meniscal healing. Sports Med Arthrosc Rev. 2013;21:206–212. doi: 10.1097/JSA.0000000000000005.

46. Kon E, Filardo G, Di Martino A, Marcacci M. Platelet-rich plasma (PRP) to treat sports injuries: evidence to support its use. Knee Surg Sports Traumatol Arthrosc. 2010;19:516–527. doi: 10.1007/s00167-010-1306-y.

47. Yin Wen-Jing, Xu Hai-Tao, Sheng Jia-Gen, An Zhi-Quan, Guo Shang-Chun, Xie Xue-Tao, Zhang Chang-Qing. Advantages of Pure Platelet-Rich Plasma Compared with Leukocyte- and Platelet-Rich Plasma in Treating Rabbit Knee Osteoarthritis. Medical Science Monitor. 2016;22:1280–1290. doi: 10.12659/MSM.898218.

48. Deasy B, Feduska J, Payne T, Li Y, Ambrosio F, Huard J. Effect of VEGF on the regenerative capacity of muscle stem cells in dystrophic skeletal muscle. Mol Ther. 2009;17:1788–1798. doi: 10.1038/mt.2009.136.

49. Le A. D. K., Enweze L., DeBaun M. R., Dragoo J. L. Platelet-RichPlasma // ClinicsinSportsMedicine. 2019. Vol. 38, № 1. P. 17–44. doi:10.1016/j.csm.2018.08.001

50. Everts P., Onishi K., Jayaram P., Lana J. F., Mautner K. Platelet-RichPlasma: NewPerformanceUnderstandingsandTherapeuticConsiderationsin 2020 // InternationalJournalofMolecularSciences. 2020. Vol.  21, № 20.

51. Chahla J, Mandelbaum B. Biological treatment for osteoarthritis of the knee: moving from bench to bedside—current practical concepts. Arthroscopy. 2018;34:1719–1729. doi: 10.1016/j.arthro.2018.01.048.

52. DEPA classification: a proposal for standardising PRP use and a retrospective application of available devices / J. Magalon, A.L. Chateau, B. Bertrand, ML Louis et al. // BMJ Open Sport – Exercise Medicine. – 2015. – Ɋ 2(1). – Ǿ. 60.

53. Sanchez M, Azofra J, Anitua E, Andia I, Padilla S, Santisteban J, Mujika I. Plasma rich in growth factors to treat an articular cartilage avulsion: a case report // Medicine & Science in Sports & Exercise. 2003. Vol.35. P. 1648-1652.

54. Scully D, Matsakas A. Current insight into the potential misuse of platelet-based applications for doping in sports // International Journal of Sports Medicine. 2019. Vol.40. P. 427-433.

55. Gato-Calvo L, Magalhaes J, Ruiz-Romero C, Blanco FJ, Burguera EF. Platelet-rich plasma: review of current evidence // Therapeutic Advances in Chronic Disease. 2019. Vol.10 P.1-18.

56. Quicke J, Foster N, Thomas M, Holden M. Is long-term physical activity safe for older adults with knee pain?: a systematic review. Osteoarthr Cartil. 2015;23:1445–1456. doi: 10.1016/j.joca.2015.05.002.

57. Felson DT, Zhang Y, Anthony JM, Naimark Anderson JJ. Weight loss reduces the risk for symptomatic knee osteoarthritis in woman. The Framingham Study. Ann Intern Med. 1992;116:535–539. doi: 10.7326/0003-4819-116-7-535.

58. Lazaridou A, Martel M, Cornelius M, Franceschelli O, Campbell C, Smith M, et al. The association between daily physical activity and pain among patients with knee osteoarthritis: the moderating role of pain catastrophizing. Pain Medicine. 2018. 10.1093/pm/pny129.

59. Saccomanno M, Donati F, Careri S, Bartoli M, Severini G, Milano G. Efficacy of intra-articular hyaluronic acid injections and exercise-based rehabilitation programme, administered as isolated or integrated therapeutic regimens for the treatment of knee osteoarthritis. Knee Surg Sports Traumatol Arthrosc. 2015;24:1686–1694. doi: 10.1007/s00167-015-3917-9.

60. Campbell K, Saltzman B, Mascarenhas R, Khair M, Verma N, Bach B, et al. Does intra-articular platelet-rich plasma injection provide clinically superior outcomes compared with other therapies in the treatment of knee osteoarthritis? A systematic review of overlapping meta-analyses. Arthroscopy. 2015;31:2213–2221. doi: 10.1016/j.arthro.2015.03.041.

61. Simental-Mendía M, Vílchez-Cavazos J, Peña-Martínez V, Said-Fernández S, Lara-Arias J, Martínez-Rodríguez H. Leukocyte-poor platelet-rich plasma is more effective than the conventional therapy with acetaminophen for the treatment of early knee osteoarthritis. Arch Orthop Trauma Surg. 2016;136:1723–1732. doi: 10.1007/s00402-016-2545-2.

62. Osterman C, McCarthy M, Cote M, Beitzel K, Bradley J, Polkowski G, et al. Platelet-rich plasma increases anti-inflammatory markers in a human coculture model for osteoarthritis. Am J Sports Med. 2015;43:1474–1484. doi: 10.1177/0363546515570463.

63. Richards M, Maxwell J, Weng L, Angelos M, Golzarian J. Intra-articular treatment of knee osteoarthritis: from anti-inflammatories to products of regenerative medicine. Phys Sportsmed. 2016;44:101–108. doi: 10.1080/00913847.2016.1168272.

64. MacMahon P, Eustace S, Kavanagh E. Injectable corticosteroid and local anesthetic preparations: a review for radiologists. Radiology. 2009;252:647–661. doi: 10.1148/radiol.2523081929.

65. Joshi Jubert N, Rodríguez L, Reverté-Vinaixa M, Navarro A. Platelet-rich plasma injections for advanced knee osteoarthritis: a prospective, randomized, double-blinded clinical trial. Orthop J Sports Med. 2017;5(2):232596711668938. doi: 10.1177/2325967116689386.

66. Forogh B, Mianehsaz E, Shoaee S, Ahadi T, Raissi GR, Sajadi S. Effect of single injection of platelet-rich plasma in comparison with corticosteroid on knee osteoarthritis: a double-blind randomized clinical trial. J Sports Med Phys Fitness. 2016;56(7–8):901–908.

67. Meheux C, McCulloch P, Lintner D, Varner K, Harris J. Efficacy of intra-articular platelet-rich plasma injections in knee osteoarthritis: a systematic review. Arthroscopy. 2016;32:495–505.

68. Filardo G, Kon E, Pereira Ruiz M, Vaccaro F, Guitaldi R, Di Martino A, et al. Platelet-rich plasma intra-articular injections for cartilage degeneration and osteoarthritis: single- versus double-spinning approach. Knee Surg Sports Traumatol Arthrosc. 2011;20:2082–2091. doi: 10.1007/s00167-011-1837-x.

69. Louis M, Magalon J, Jouve E, Bornet C, Mattei J, Chagnaud C, et al. Growth factors levels determine efficacy of platelets rich plasma injection in knee osteoarthritis: a randomized double blind noninferiority trial compared with viscosupplementation. Arthroscopy. 2018;34:1530–1540.e2. doi: 10.1016/j.arthro.2017.11.035.

70. Filardo G, Di Matteo B, Di Martino A, Merli M, Cenacchi A, Fornasari P, et al. Platelet-rich plasma intra-articular knee injections show no superiority versus viscosupplementation. Am J Sports Med. 2015;43:1575–1582. doi: 10.1177/0363546515582027.

71. Görmeli G, Görmeli C, Ataoglu B, Çolak C, Aslantürk O, Ertem K. Multiple PRP injections are more effective than single injections and hyaluronic acid in knees with early osteoarthritis: a randomized, double-blind, placebo-controlled trial. Knee Surg Sports Traumatol Arthrosc. 2015;25:958–965. doi: 10.1007/s00167-015-3705-6.

72. Duymus T, Mutlu S, Dernek B, Komur B, Aydogmus S, Kesiktas F. Choice of intra-articular injection in treatment of knee osteoarthritis: platelet-rich plasma, hyaluronic acid or ozone options. Knee Surg Sports Traumatol Arthrosc. 2016;25:485–492. doi: 10.1007/s00167-016-4110-5.

73. Vaquerizo Víctor, Plasencia Miguel Ángel, Arribas Ignacio, Seijas Roberto, Padilla Sabino, Orive Gorka, Anitua Eduardo. Comparison of Intra-Articular Injections of Plasma Rich in Growth Factors (PRGF-Endoret) Versus Durolane Hyaluronic Acid in the Treatment of Patients With Symptomatic Osteoarthritis: A Randomized Controlled Trial. Arthroscopy: The Journal of Arthroscopic & Related Surgery. 2013;29(10):1635–1643. doi: 10.1016/j.arthro.2013.07.264.

74. Dai WL, Zhou AG, Zhang H, et al. Efficacy of platelet-rich plasma in the treatment of knee osteoarthritis: a meta-analysis of randomized controlled trials. Arthroscopy. 2017;33(3):659–70. https://doi.org/10.1016/j.arthro.2016.09.024.

75. Cole B, Karas V, Hussey K, Merkow D, Pilz K, Fortier L. Hyaluronic acid versus platelet-rich plasma: a prospective, double-blind randomized controlled trial comparing clinical outcomes and effects on intra-articular biology for the treatment of knee osteoarthritis. Am J Sports Med. 2016;45:339–346. doi: 10.1177/0363546516665809.

76. Kanchanatawan W, Arirachakaran A, Chaijenkij K, et al. Short-term outcomes of platelet-rich plasma injection for treatment of osteoarthritis of the knee. Knee Surg Sports Traumatol Arthrosc. 2016;24(5):1665 77. https://doi.org/10.1007/s00167-015-3784-4.

77. Xu Z, Luo J, Huang X, et al. Efficacy of platelet-rich plasma in pain and self-report function in knee osteoarthritis: a best-evidence synthesis. Am J Phys Med Rehabil. 2017;96(11):793–800. https://doi.org/10.1097/PHM.0000000000000746.

78. Filardo G, Kon E, Pereira Ruiz M, Vaccaro F, Guitaldi R, Di Martino A, et al. Platelet-rich plasma intra-articular injections for cartilage degeneration and osteoarthritis: single- versus double-spinning approach. Knee Surg Sports Traumatol Arthrosc. 2011;20:2082–2091. doi: 10.1007/s00167-011-1837-x.

79. Hurley Eoghan T., Yasui Youichi, Gianakos Arianna L., Seow Dexter, Shimozono Yoshiharu, Kerkhoffs Gino M. M. J., Kennedy John G. Limited evidence for adipose-derived stem cell therapy on the treatment of osteoarthritis. Knee Surgery, Sports Traumatology, Arthroscopy. 2018;26(11):3499–3507. doi: 10.1007/s00167-018-4955-x.

80. Chahla J, Piuzzi N, Mitchell J, Dean C, Pascual-Garrido C, LaPrade R, et al. Intra-articular cellular therapy for osteoarthritis and focal cartilage defects of the knee. J Bone Joint Surg. 2016;98:1511–1521. doi: 10.2106/JBJS.15.01495.

81. Koh Y, Choi Y. Infrapatellar fat pad-derived mesenchymal stem cell therapy for knee osteoarthritis. Knee. 2012;19:902–907. doi: 10.1016/j.knee.2012.04.001.

82. Kim J, Lee G, Jung G, Kim C, Kim T, Park J, et al. Clinical outcome of autologous bone marrow aspirates concentrate (BMAC) injection in degenerative arthritis of the knee. European Journal of Orthopaedic Surgery & Traumatology. 2014;24:1505–1511. doi: 10.1007/s00590-013-1393-9.

83. Centeno C, Pitts J, Al-Sayegh H, Freeman M. Efficacy of autologous bone marrow concentrate for knee osteoarthritis with and without adipose graft. Biomed Res Int. 2014;2014:1–9. doi: 10.1155/2014/370621.

84. Shapiro S, Kazmerchak S, Heckman M, Zubair A, O’Connor M. A prospective, single-blind, placebo-controlled trial of bone marrow aspirate concentrate for knee osteoarthritis. Am J Sports Med. 2016;45:82–90. doi: 10.1177/0363546516662455.

85. Anitua E, Sanchez M, De la Fuente M, Zalduendo MM, Orive G. Plasma rich in growth factors (PRGF-Endoret) stimulates tendon and synovial fibroblasts migration and improves the biological properties of hyaluronic acid. Knee Surg Sports Traumatol Arthrosc. 2012;20(9):1657–1665. doi: 10.1007/s00167-011-1697-4.

86. Marmotti A, Bruzzone M, Bonasia DE, Castoldi F, Rossi R, Piras L, Maiello A, Realmuto C, Peretti GM. One-step osteochondral repair with cartilage fragments in a composite scaffold. Knee Surg Sports Traumatol Arthrosc. 2012;20(12):2590–2601. doi: 10.1007/s00167-012-1920-y.

87. Lin KY, Yang CC, Hsu CJ, Yeh ML, Renn JK. Intra-articular injection of platelet-rich plasma is superior to hyaluronic acid or saline solution in the treatment of mild to moderate knee osteoarthritis: a randomized, double-blind, triple-parallel, placebo-controlled clinical trial. Arthroscopy: The Journal of Arthroscopic and Related Surgery. 2019;35(1):106-117.

88.   Wang-Saegusa A, Cugat R, Ares O, Seijas R, Cuscó X, Garcia-Balletbó M. Infiltration of plasma rich in growth factors for osteoarthritis of the knee short-term effects on function and quality of life. Arch Orthop Trauma Surg. 2011;131(3):311–7.

89. Carballo C. B., Nakagawa Y., Sekiya I., etal. Basicscienceofarticularcartilage // ClinSportsMed 2017. Vol. 36, № 3. P. 413–425.

90. Cook CS, Smith PA. Clinical update: why PRP should be your first choice for injection therapy in treating osteoarthritis of the knee // Current Reviews in Musculosceletal Medicine. 2018. Vol.11. P. 583-592.

91. Chahla J, Cinque M, Piuzzi N, Mannava S, Geeslin A, Murray I, et al. A call for standardization in platelet-rich plasma preparation protocols and composition reporting. J Bone Joint Surg Am. 2017;99:1769–1779. doi: 10.2106/JBJS.16.01374.

Конфликт интересов. Авторы заявляют об отсутствии конфликта интересов.
Финансирование. Исследование не имело спонсорской поддержки.
Участие авторов. Cтатья подготовлена с равным участием авторов.
Поступила: 25.03.2023. Принята к публикации: 26.04.2023.